... informed consent form The study was not funded or supported by any organization, group or individual Results During the six inclusion years there were 2, 207 ICU admissions, 1, 822 with no history ... vs normoglycaemia - sepsisa 376 164 (43.6%) 20 2 (56.4%) P < 0.001 ACSb Diagnoses (N, %) 322 97 (30.1%) 22 5 (69.9%) - other diagnoses 331 99 (29 .9%) 23 2 (70.1%) Age (years) 58 (19 to 87) 59 (22 ... secondary prevention to reduce and delay incidence of typediabetes [51] In a recent paper [ 52] , 20 cohort studies of GD that included control group were identified; cumulative relative risk for type...
... 100 ml) 120 ± 25 126 ± 23 133 ± 57 Plasma [glucose] posttraining (mg / 100 ml) 115 ± 22 120 ± 22 122 ± 35 Significance n.s n.s n.s HbA1C At baseline the HbA1c amounted to 6,7 % ± 0 ,26 (FT), 6,8 ... Rehabil 20 05; 86: 1 527 – 33 Dunstan DW, Daly RM, Owen N, et al High-intensity resistance training improves glycemic control in older patients with typediabetesDiabetes care 20 02; 25 : 1 729 – 36 ... six weeks, one set was performed with the positions kept for 20 s each From week to volume was increased by one more set During the last three weeks two sets with exercise durations of 30 s were...
... (Millipore Corp., Bedford, MA) Then, the PVDF membranes were blotted with QIS30, anti GLUT4 or anti GAPDH (CSA-335, Stressgen, Victoria, Canada) at 1 :2, 000 in PBS + Tween 20 + 2% BSA for hr at ... Care in DiabetesDiabetes Care 20 05 ;28 (suppl_1):S4-S36 24 Sigal RJ, Kenny GP, Wasserman DH, Castaneda-Sceppa C Physical activity/exercise and typediabetesDiabetes Care 20 04 ;27 (10) :25 18-39 25 Hjeltnes ... 1993 ;26 4(6 Pt 1):E855- 62 22 Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS Racial and ethnic differences in glycemic control of adults with typediabetesDiabetes Care 1999 ;22 (3):403-8 23 ...
... 1,795 (22 %) 110 (18%) 38 (18%) 1,685 (23 %) 60-65 1,446 (18%) 122 (20 %) 45 (21 %) 1, 324 (18%) ≥ 65 2, 024 (25 %) 29 1 (47%) 1 02 (48%) 1,733 (24 %) BMI (kg·m -2) < 18.5 51 (1%) (1%) (1%) 48 (1%) 18.5 -25 .0 ... m or 25 0 m Table Characteristics of the total population and of participants with and without typediabetes Characteristic Total population TypeDiabetes Screening diagnosed TypeDiabetes No Type ... described in more detail elsewhere [ 12] In brief, between 1998 and 20 00, all 50- to 75-year-old residents of the study area were invited to participate in the Hoorn Screening Study for type diabetes...
... Acknowledgements Preface v vii viii DEVELOPMENT OF THE GUIDELINE 1.1 1 .2 1.3 1.4 2. 1 2.22. 3 2. 4 2. 5 2. 6 2. 7 2. 8 2. 9 2. 10 3.1 3 .2 Introduction Background Definition Prevalence Health and resource ... neuropathy 23 5 24 6 24 7 25 0 25 5 Areas for future research 25 7 REFERENCES 25 9 13 17 18 18.1 18 .2 18.3 18.4 18.5 19 iv Members of the Guideline Development Group Professor Jonathan Mant (Chair) Professor ... Monitor for worsening or remission Consider a trial of another of duloxetine, gabapentin, or pregabalin – titrate dose and monitor for response Controlled Uncontrolled* Monitor for worsening or...
... relationship between diabetes and FVL gene variants both for typeortypediabetes but not univocal data were found [14-16] Krekora et al in fact suspected also a possible genetic co-segregation for both ... factor for VTE, in particular for idiopathic VTE [8] We performed a retrospective analysis of nearly 7000 patients referred to our Thrombosis Center for one or more episode of thrombotic disorders ... (e.g A1691G of factor V and \or prothrombin A2 021 0G) or other thrombotic risk factor Factor V Leiden (FVL) is a well known inherited thrombophilic condition both in heterozygosity or in homozygosity...
... 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 patients with typediabetes mellitus JAMA 20 09, 301:1565-15 72 American Diabetes Association Workgroup on Hypoglycemia: Defining and reporting ... scores between patients who report a 'small improvement' and those who felt 'a little worse', or between patients who report a 'small improvement' and those who reported 'no change' [22 ,23 ,29 ,36] ... Weight (kg) BMI (kg/m2) History of complications Macrovascular Microvascular Duration of diabetes, years 9 62. 7 (10.6) 42. 6% 57.4% 62. 8% 7 .24 (1 .23 ) 29 .1% 87.3 (15.8) 29 .6 (4.6) 28 .9%...
... Panminerva Med 20 00, 42: 23 -26 25 Jick SS, Stender M, Myers MW: Frequency of liver disease in type diabetic patients treated with oral antidiabetic agents Diabetes Care 1999, 22 :20 67 -20 71 26 UK Hypoglycaemia ... Intern Med 20 05, 165 :23 4 -24 0 Ligthelm RJ, Borzì V, Gumprecht J, Kawamori R, Wenying Y, Valensi P: Importance of observational studies in clinical practice Clin Ther 20 07, 29 : 128 4- 129 2, Spec No ... patients to lower risk patients (category A) by including only patients with less severe diabetes [20 ,26 ,27 ,31-33] or patients on monotherapy [19 ,24 ,27 ,33-36], or OAD-naïve patients [27 ,35] or by excluding...